Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
Gyamfi-Bannerman C, Thom E, Blackwell S, Tita A, Reddy U, Saade G, Rouse D, McKenna D, Clark E, Thorp J, Chien E, Peaceman A, Gibbs R, Swamy G, Norton M, Casey B, Caritis S, Tolosa J, Sorokin Y, VanDorsten J, Jain L. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. Obstetrical & Gynecological Survey 2016, 71: 453-455. DOI: 10.1097/01.ogx.0000489576.69844.54.Peer-Reviewed Original ResearchLate preterm periodPreterm periodMaternal-Fetal Medicine Units NetworkEunice Kennedy Shriver National InstituteLate preterm deliveryAdministration of betamethasoneAntenatal betamethasoneNeonatal morbidityPreterm deliveryMulticenter trialClinical centersChildhood complicationsChild healthNational InstituteBetamethasoneWomenRiskMorbidityComplicationsNewbornsInfantsAdministrationTrials